Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 


Medical devices powered by the ear itself

For the first time, researchers power an implantable electronic device using an electrical potential — a natural battery — deep in the inner ear.

Deep in the inner ear of mammals is a natural battery — a chamber filled with ions that produces an electrical potential to drive neural signals.

In today’s issue of the journal Nature Biotechnology, a team of researchers from MIT, the Massachusetts Eye and Ear Infirmary (MEEI) and the Harvard-MIT Division of Health Sciences and Technology (HST) demonstrate for the first time that this battery could power implantable electronic devices without impairing hearing.

The devices could monitor biological activity in the ears of people with hearing or balance impairments, or responses to therapies. Eventually, they might even deliver therapies themselves.

In experiments, Konstantina Stankovic, an otologic surgeon at MEEI, and HST graduate student Andrew Lysaght implanted electrodes in the biological batteries in guinea pigs’ ears. Attached to the electrodes were low-power electronic devices developed by MIT’s Microsystems Technology Laboratories (MTL). After the implantation, the guinea pigs responded normally to hearing tests, and the devices were able to wirelessly transmit data about the chemical conditions of the ear to an external receiver.

“In the past, people have thought that the space where the high potential is located is inaccessible for implantable devices, because potentially it’s very dangerous if you encroach on it,” Stankovic says. “We have known for 60 years that this battery exists and that it’s really important for normal hearing, but nobody has attempted to use this battery to power useful electronics.”

The ear converts a mechanical force — the vibration of the eardrum — into an electrochemical signal that can be processed by the brain; the biological battery is the source of that signal’s current. Located in the part of the ear called the cochlea, the battery chamber is divided by a membrane, some of whose cells are specialized to pump ions. An imbalance of potassium and sodium ions on opposite sides of the membrane, together with the particular arrangement of the pumps, creates an electrical voltage.

Although the voltage is the highest in the body (outside of individual cells, at least), it’s still very low. Moreover, in order not to disrupt hearing, a device powered by the biological battery can harvest only a small fraction of its power. Low-power chips, however, are precisely the area of expertise of Anantha Chandrakasan’s group at MTL.

The MTL researchers — Chandrakasan, who heads MIT’s Department of Electrical Engineering and Computer Science; his former graduate student Patrick Mercier, who’s now an assistant professor at the University of California at San Diego; and Saurav Bandyopadhyay, a graduate student in Chandrakasan’s group — equipped their chip with an ultralow-power radio transmitter: After all, an implantable medical monitor wouldn’t be much use if there were no way to retrieve its measurements.

But while the radio is much more efficient than those found in cellphones, it still couldn’t run directly on the biological battery. So the MTL chip also includes power-conversion circuitry — like that in the boxy converters at the ends of many electronic devices’ power cables — that gradually builds up charge in a capacitor. The voltage of the biological battery fluctuates, but it would take the control circuit somewhere between 40 seconds and four minutes to amass enough charge to power the radio. The frequency of the signal was thus itself an indication of the electrochemical properties of the inner ear.

To reduce its power consumption, the control circuit had to be drastically simplified, but like the radio, it still required a higher voltage than the biological battery could provide. Once the control circuit was up and running, it could drive itself; the problem was getting it up and running.

The MTL researchers solve that problem with a one-time burst of radio waves. “In the very beginning, we need to kick-start it,” Chandrakasan says. “Once we do that, we can be self-sustaining. The control runs off the output.”

Stankovic, who still maintains an affiliation with HST, and Lysaght implanted electrodes attached to the MTL chip on both sides of the membrane in the biological battery of each guinea pig’s ear. In the experiments, the chip itself remained outside the guinea pig’s body, but it’s small enough to nestle in the cavity of the middle ear.

Cliff Megerian, chairman of the otolaryngology department at Case Western Reserve University, says that he sees three possible applications of the researchers’ work: in cochlear implants, diagnostics and implantable hearing aids. “The fact that you can generate the power for a low voltage from the cochlea itself raises the possibility of using that as a power source to drive a cochlear implant,” Megerian says. “Imagine if we were able to measure that voltage in various disease states. There would potentially be a diagnostic algorithm for aberrations in that electrical output.”

“I’m not ready to say that the present iteration of this technology is ready,” Megerian cautions. But he adds that, “If we could tap into the natural power source of the cochlea, it could potentially be a driver behind the amplification technology of the future.”

The work was funded in part by the Focus Center Research Program, the National Institute on Deafness and Other Communication Disorders, and the Bertarelli Foundation.

Kimberly Allen | EurekAlert!
Further information:

More articles from Power and Electrical Engineering:

nachricht Cost-efficiently modernising heating networks
11.02.2016 | FIZ Karlsruhe – Leibniz-Institut für Informationsinfrastruktur GmbH

nachricht Demonstration of smart energy storage technologies and -management systems on the island of Borkum
11.02.2016 | Steinbeis-Europa-Zentrum

All articles from Power and Electrical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Einzeller mit Durchblick: Wie Bakterien „sehen“

Ein 300 Jahre altes Rätsel der Biologie ist geknackt. Wie eine internationale Forschergruppe aus Deutschland, Großbritannien und Portugal herausgefunden hat, nutzen Cyanobakterien – weltweit vorkommende mikroskopisch kleine Einzeller – das Funktionsprinzip des Linsenauges, um Licht wahrzunehmen und sich darauf zuzubewegen. Der Schlüssel zu des Rätsels Lösung war eine Idee aus Karlsruhe: Jan Gerrit Korvink, Professor am KIT und Leiter des Instituts für Mikrostrukturtechnik (IMT) am KIT, nutzte Siliziumplatten und UV-Licht, um den Brechungsindex der Einzeller zu messen.


Im Focus: Production of an AIDS vaccine in algae

Today, plants and microorganisms are heavily used for the production of medicinal products. The production of biopharmaceuticals in plants, also referred to as “Molecular Pharming”, represents a continuously growing field of plant biotechnology. Preferred host organisms include yeast and crop plants, such as maize and potato – plants with high demands. With the help of a special algal strain, the research team of Prof. Ralph Bock at the Max Planck Institute of Molecular Plant Physiology in Potsdam strives to develop a more efficient and resource-saving system for the production of medicines and vaccines. They tested its practicality by synthesizing a component of a potential AIDS vaccine.

The use of plants and microorganisms to produce pharmaceuticals is nothing new. In 1982, bacteria were genetically modified to produce human insulin, a drug...

Im Focus: Weltweit genaueste optische Einzelionen-Uhr

Als erste Forschergruppe weltweit haben Atomuhren-Spezialisten der Physikalisch-Technischen Bundesanstalt (PTB) jetzt eine optische Einzelionen-Uhr gebaut, die eine bisher nur theoretisch vorhergesagte Genauigkeit erreicht. Ihre optische Ytterbium-Uhr erreichte eine relative systematische Messunsicherheit von 3 E-18. Die Ergebnisse sind in der aktuellen Ausgabe der Fachzeitschrift Physical Review Letters veröffentlicht.

Als erste Forschergruppe weltweit haben Atomuhren-Spezialisten der Physikalisch-Technischen Bundesanstalt (PTB) jetzt eine optische Einzelionen-Uhr gebaut, die...

Im Focus: The most accurate optical single-ion clock worldwide

Atomic clock experts from the Physikalisch-Technische Bundesanstalt (PTB) are the first research group in the world to have built an optical single-ion clock which attains an accuracy which had only been predicted theoretically so far. Their optical ytterbium clock achieved a relative systematic measurement uncertainty of 3 E-18. The results have been published in the current issue of the scientific journal "Physical Review Letters".

Atomic clock experts from the Physikalisch-Technische Bundesanstalt (PTB) are the first research group in the world to have built an optical single-ion clock...

Im Focus: Autonome Nanosatelliten in Arbeit

Zwei neue Weltraumprojekte werden an der Universität Würzburg vorbereitet: Sie sollen unter anderem die Beobachtung von Planeten und die autonome Fehlerkorrektur an Bord von Satelliten ermöglichen. Das Bundeswirtschaftsministerium fördert die Projekte mit rund 1,6 Millionen Euro.

Wirbelstürme erkennen, die über den Mars fegen. Meteore detektieren, die auf die Erde hinabstürzen. Ungewöhnliche Blitze erforschen, die aus der Erdatmosphäre...

Alle Focus-News des Innovations-reports >>>



im innovations-report
in Kooperation mit academics

Deutsche Gesellschaft für Verhaltensmedizin und Verhaltensmodifikation tagt in Mainz

10.02.2016 | Veranstaltungen

Bericht zur weltweiten Lage der Bestäuber

10.02.2016 | Veranstaltungen

18. Chemnitzer Linux-Tage: "Es ist Dein Projekt"

10.02.2016 | Veranstaltungen

Weitere VideoLinks >>>
Aktuelle Beiträge

Einzeller mit Durchblick: Wie Bakterien „sehen“

11.02.2016 | Biowissenschaften Chemie

Gewebeschäden des Herzmuskels bis ins Detail sichtbar

11.02.2016 | Medizintechnik

Nanofabriken der Zelle: ForscherInnen der Uni Graz entschlüsseln Entstehungsmechanismus

11.02.2016 | Biowissenschaften Chemie